These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3532772)

  • 1. A comparison of inpatient and outpatient Medicare allowable charges for continuous ambulatory peritoneal and center hemodialysis patients: a single-center study.
    Prowant BF; Kappel DF; Campbell A
    Am J Kidney Dis; 1986 Oct; 8(4):248-52. PubMed ID: 3532772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of charges for continuous ambulatory peritoneal dialysis and center hemodialysis.
    Smith DG; Wheeler JR
    J Clin Epidemiol; 1988; 41(9):817-24. PubMed ID: 3053998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing a peritoneal dialysis program's cost by changing from a vendor-provided to a program-provided system for general medical supplies: significant savings in CCPD.
    Holley JL; McGuirl K; Smith S; Caswell N
    Am J Kidney Dis; 1998 Apr; 31(4):662-5. PubMed ID: 9531183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis.
    Cortés-Sanabria L; Paredes-Ceseña CA; Herrera-Llamas RM; Cruz-Bueno Y; Soto-Molina H; Pazarín L; Cortés M; Martínez-Ramírez HR
    Arch Med Res; 2013 Nov; 44(8):655-61. PubMed ID: 24211750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proposed reimbursement regulation.
    Hanson K
    Nephrol Nurse; 1982; 4(3):12-6. PubMed ID: 6919761
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of capitation on free-standing dialysis facilities: can you survive?
    McMurray SD; Miller J
    Am J Kidney Dis; 1997 Oct; 30(4):542-8. PubMed ID: 9328370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home dialysis costs less than outpatient dialysis.
    Blagg CR
    N Engl J Med; 1982 Feb; 306(7):431. PubMed ID: 7035952
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
    Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
    Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs.
    Hirth RA; Held PJ; Orzol SM; Dor A
    Health Serv Res; 1999 Feb; 33(6):1567-92. PubMed ID: 10029498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Medicare cost of renal dialysis. Evidence from a statistical cost function.
    Dor A; Held PJ; Pauly MV
    Med Care; 1992 Oct; 30(10):879-91. PubMed ID: 1405794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients.
    Coyte PC; Young LG; Tipper BL; Mitchell VM; Stoffman PR; Willumsen J; Geary DF
    Am J Kidney Dis; 1996 Apr; 27(4):557-65. PubMed ID: 8678067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
    Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
    Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of dialysis modalities in Italy.
    Tediosi F; Bertolini G; Parazzini F; Mecca G; Garattini L
    Health Serv Manage Res; 2001 Feb; 14(1):9-17. PubMed ID: 11246787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Views of Japanese patients on the advantages and disadvantages of hemodialysis and peritoneal dialysis.
    Nakamura-Taira N; Muranaka Y; Miwa M; Kin S; Hirai K
    Int Urol Nephrol; 2013 Aug; 45(4):1145-58. PubMed ID: 23161376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
    Cellini GL
    Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of diagnosis-related groups on the cost of hospitalization for end-stage renal disease patients at Rhode Island Hospital from 1987 to 1990.
    Chazan JA; London MR; Pono L
    Am J Kidney Dis; 1992 Jun; 19(6):523-5. PubMed ID: 1595699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of costs and quality of life of chronic ambulatory peritoneal dialysis and hemodialysis patients in Israel.
    Rozenbaum EA; Pliskin JS; Barnoon S; Chaimovitz C
    Isr J Med Sci; 1985 Apr; 21(4):335-9. PubMed ID: 3997497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial effect of clinical decisions: case study of a dialysis center.
    Balas EA; Hicks LL; Stone JV; Ponferrada LP; West DA
    J Med Syst; 1995 Dec; 19(6):465-74. PubMed ID: 8750377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.